Renaud Bonnet > Jones Day > Paris, France > Lawyer Profile

Jones Day
2 RUE SAINT-FLORENTIN
75001 PARIS
France
Renaud Bonnet photo

Work Department

Private Equity; M&A; Technology; Health Care & Life Sciences

Position

Partner

Career

Renaud Bonnet, co-chair of Jones Day’s global Private Equity Practice, practices in the areas of venture capital, private equity, M&A and capital markets. Renaud primarily represents technology and life sciences companies, and the private equity and industrial investors that finance them, at every stage of development, from entrepreneurial start-ups to multibillion-dollar global corporations. He has served as principal lawyer in a significant number of early to late stage financing rounds, M&A and buy-out transactions, IPOs and tender offers. Renaud is a member of the Corporate Finance Committee of France Biotech.

Languages

English, French

Education

  • Columbia University (LL.M. 1997;
  • Harlan Fiske Stone Scholar); Université de Paris II-Panthéon Assas (DESS/DJCE in Business Law and Taxation 1994;
  • Double Maîtrise with honors and high honors 1993);
  • ESSEC Graduate School of Management (MBA 1993);
  • Institut d’Etudes Politiques de Paris (Sciences Po) (Diplôme — section Service Public 1991)

Lawyer Rankings

France > Capital markets: equity capital markets

Jones Day combines strong US and French ECM expertise within its Paris office, and has a strong involvement alongside issuers including a number of startups and biotech companies, while also assisting several banks and arrangers. The practice regularly assists clients with share capital increase and IPO transactions and also handles convertible work. On the US front, it assists clients with SEC registration and US private placement needs. The team also stands out for its ability to assist dual-listed French issuers on their US registered Yankee bond programmes. The team is jointly headed by US expert Linda HesseFlorent Bouyer, and Renaud Bonnet. Charles Gavoty also contributes.

France > Industry focus: Healthcare and life sciences

Leveraging their European network of offices, Jones Day acts for its lucrative client base on a broad range of IP disputes and transactions. The group regularly advises on IPOs, M&A, and disputes concerning patent infringements and license agreement breaches. Practice co-head and environmental law specialist Françoise Labrousse maintains a strong reputation for handling contentious matters. Co-head Renaud Bonnet is known for his deep knowledge of private equity related issues, and for advising a broad array of technology and life sciences clients, and investors.

France > Private equity: venture/growth capital

(Leading individuals)

Renaud BonnetJones Day

Praised by one client for its ‘very detailed knowledge of venture capital market practices’ and billed by another as ‘the reference in Paris’, the Jones Day team excels at delivering counsel on venture and growth capital matters, from seed to late stage financing. The group assists start-ups and multinationals alike and has particular expertise with regards the tech and biotech segments. The practice is jointly led by a group of four partners, comprising: Renaud BonnetCharles GavotyJean-Gabriel Griboul, and Geoffroy Pineau-ValencienneAnne Kerneur is an additional key contact. Alexandre Wibaux relocated to the firm’s New York office.